Literature DB >> 36117928

Fatigue, anxiety and depression in patients with prediabetes: a controlled cross-sectional study.

Ulaş Serkan Topaloğlu1, Kemal Erol2.   

Abstract

Objective: We aimed to determine fatigue, depression, anxiety levels, and quality of life (QoL) in patients with prediabetes (PD) and to compare them with healthy subjects. Materials and methods: A controlled, cross-sectional study was conducted. The patients, aged 18-65, were recruited from a tertiary care hospital. A total of 105 patients with newly diagnosed untreated PD and 48 normoglycemic subjects were included in the study. Participants did not know the diagnosis of PD and did not give psychological distress to the newly diagnosed. All participants were evaluated for body mass index (BMI), oral glucose tolerance test (OGTT), glycated hemoglobin (HbA1c), Fatigue Severity Scale (FSS), Hospital Anxiety and Depression Scale (HADS), Short Form-36 (SF-36).
Results: Age, gender, BMI were similar between groups. The scores of psychological measures were significantly worse in patients with PD compared with normoglycemic subjects (FSS median score: 4.33 vs. 2.22, HADS-anxiety mean score: 7.53 vs. 2.64, HADS-depression mean score: 6.33 vs. 2.79, SF-36 total median score: 52.81 vs. 79.89). The FSS, HADS and SF-36 scores showed a weak but statistically significant relationship with BMI. OGTT, HbA1c and HOMA-IR did not show any relationship with these scores.
Conclusion: Psychosocial problems may present in the prediabetic stage before the onset of diabetes. © The Japan Diabetes Society 2022.

Entities:  

Keywords:  Anxiety; Depression; Fatigue; Prediabetes, quality of life

Year:  2022        PMID: 36117928      PMCID: PMC9477980          DOI: 10.1007/s13340-022-00583-0

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  24 in total

1.  The homeostasis model in the San Antonio Heart Study.

Authors:  S M Haffner; H Miettinen; M P Stern
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

2.  Validation of the fatigue severity scale in a Swiss cohort.

Authors:  Philipp O Valko; Claudio L Bassetti; Konrad E Bloch; Ulrike Held; Christian R Baumann
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

3.  Associations Between Depressive Symptoms and Indices of Obesity in Adults With Prediabetes and Normal Blood Glucose Levels: Results From the Emotional Health and Wellbeing Study.

Authors:  Rachel J Burns; Sonya S Deschênes; Norbert Schmitz
Journal:  Can J Diabetes       Date:  2018-05-23       Impact factor: 4.190

4.  Comparison of Level of Fatigue and Disease Correlates in Patients With Rheumatoid Arthritis and Systemic Sclerosis.

Authors:  Kevser Gök; Kemal Erol; Gizem Cengiz; Salih Özgöçmen
Journal:  Arch Rheumatol       Date:  2018-01-15       Impact factor: 1.472

5.  Fatigue and sleep in children and adolescents with juvenile idiopathic arthritis:a cross-sectional study

Authors:  Ela Tarakçı; Nilay Arman; Kenan Barut; Sezgin Şahin; Amra Adroviç; Özgür Kasapçopur
Journal:  Turk J Med Sci       Date:  2019-02-11       Impact factor: 0.973

6.  Translation, cultural adaptation, cross-validation of the Turkish diabetes quality-of-life (DQOL) measure.

Authors:  Aysegul Yildirim; Fevzi Akinci; Hulya Gozu; Haluk Sargin; Ekrem Orbay; Mehmet Sargin
Journal:  Qual Life Res       Date:  2007-02-08       Impact factor: 3.440

Review 7.  Quality of Life in Chronic Disease Patients.

Authors:  Kalliopi Megari
Journal:  Health Psychol Res       Date:  2013-09-23

8.  Diabetes Fatigue Syndrome.

Authors:  Sanjay Kalra; Rakesh Sahay
Journal:  Diabetes Ther       Date:  2018-06-04       Impact factor: 2.945

Review 9.  A Qualitative Metasynthesis of the Experience of Fatigue Across Five Chronic Conditions.

Authors:  Rosario B Jaime-Lara; Brittany C Koons; Lea Ann Matura; Nancy A Hodgson; Barbara Riegel
Journal:  J Pain Symptom Manage       Date:  2019-12-20       Impact factor: 3.612

10.  The Turkish Version of Multidimensional Assessment of Fatigue and Fatigue Severity Scale is Reproducible and Correlated With Other Outcome Measures in Patients With Systemic Sclerosis.

Authors:  Kevser Gök; Gizem Cengiz; Kemal Erol; Salih Özgöçmen
Journal:  Arch Rheumatol       Date:  2016-05-17       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.